Seroatlas · Human Serome Atlas

FCER1A

High affinity immunoglobulin epsilon receptor subunit alpha

Also known as: FCE1A, FcepsilonRIalpha, FCERA_HUMAN, FCERIA

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P12319
Gene
FCER1A
Ensembl
ENSG00000179639
Chromosome
1
Canonical length
257 aa
Protein class
FDA approved drug targets, Predicted membrane proteins

OverviewNCBI Gene

The immunoglobulin epsilon receptor (IgE receptor) is the initiator of the allergic response. When two or more high-affinity IgE receptors are brought together by allergen-bound IgE molecules, mediators such as histamine that are responsible for allergy symptoms are released. This receptor is comprised of an alpha subunit, a beta subunit, and two gamma subunits. The protein encoded by this gene represents the alpha subunit. [provided by RefSeq, Aug 2011]

Canonical amino-acid sequenceUniProt

257 residues, UniProt reviewed canonical sequence.

>P12319|FCER1A
     1  MAPAMESPTL LCVALLFFAP DGVLAVPQKP KVSLNPPWNR IFKGENVTLT CNGNNFFEVS
    61  STKWFHNGSL SEETNSSLNI VNAKFEDSGE YKCQHQQVNE SEPVYLEVFS DWLLLQASAE
   121  VVMEGQPLFL RCHGWRNWDV YKVIYYKDGE ALKYWYENHN ISITNATVED SGTYYCTGKV
   181  WQLDYESEPL NITVIKAPRE KYWLQFFIPL LVVILFAVDT GLFISTQQQV TFLLKIKRTR
   241  KGFRLLNPHP KPNPKNN

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against FCER1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.4
Highest tissue expression
35 nTPM

Expression across tissuesHPA

Tissue

  • skin: 35 nTPM
  • esophagus: 24 nTPM
  • breast: 18 nTPM
  • gallbladder: 16 nTPM
  • lung: 15 nTPM
  • bone marrow: 15 nTPM

Single-cell type

  • cdc: 1,200 nCPM
  • mast cells: 155 nCPM
  • macrophages: 149 nCPM
  • megakaryocyte progenitors: 115 nCPM
  • megakaryocyte-erythroid progenitors: 98 nCPM
  • pdcs: 96 nCPM

Immune cell

  • basophil: 21,795 nTPM
  • myeloid DC: 2,656 nTPM
  • plasmacytoid DC: 365 nTPM
  • total PBMC: 133 nTPM
  • eosinophil: 37 nTPM
  • neutrophil: 17 nTPM

Brain region

  • pons: 0.8 nTPM
  • hypothalamus: 0.7 nTPM
  • choroid plexus: 0.5 nTPM
  • medulla oblongata: 0.5 nTPM
  • midbrain: 0.4 nTPM
  • white matter: 0.4 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about FCER1A.

Disease | AutoantibodyPubMed

Conditions in which antibodies against FCER1A are reported. Each links to that disease's full target list.

Showing 1 of 2 — disease pages carrying at least 10 antigens.

ReferencesPubMed · IEDB

Publications for FCER1A from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Reference: AutoantibodyPubMed

36 publications

Show 20 more of 36 total

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.37
gnomAD pLI
0
gnomAD missense Z
-0.42
DepMap mean gene effect
-0.01
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of FCER1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads FCER1A as an antibody target. Whether an autoantibody or antibody against FCER1A could matter depends on whether native FCER1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

FCER1A is annotated at the cell surface, where native FCER1A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label FCER1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/FCER1A. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...